Listing 1 - 6 of 6 |
Sort by
|
Choose an application
This book includes a collection of eight original research articles and three reviews covering a wide range of topics in the field of kinetoplastids. In addition, readers can find a compendium of molecular biology procedures and bioinformatics tools.
Research & information: general --- Biology, life sciences --- trypanosomatids --- yeasts --- trypanosomatids genome --- cell cycle phases --- S-phase duration --- DNA replication --- replication origins --- neglected tropical diseases --- Leishmania --- Trypanosoma cruzi --- Trypanosoma brucei --- drug discovery --- in vitro models --- in vivo models --- genomics --- drug resistance --- Leishmania infantum --- proteome --- post-translational modifications (PTMs) --- proteogenomics --- mass spectrometry --- Retrotransposon Hot Spot (RHS) multigene family --- chromosome distribution --- recombination --- gene mosaic structure --- evolution --- nuclear protein --- Leishmania braziliensis --- reverse genetics --- CRISPR–Cas9 --- gene targeting --- phenotyping --- heat shock proteins --- Trypanosoma cruzi strain --- sequencing methods --- genome plasticity --- gene expression --- trans-sialidases --- mucins --- SENP --- Ulp2 --- SUMO --- CRISPR --- protease --- genome --- repeats --- 3′UTR --- multigenic family --- Leishmania donovani --- whole-genome sequencing (WGS) --- transcriptome --- artemisinin drug resistance --- Leishmania viruses --- phylogeny --- coevolution --- endosymbiont protozoan viruses --- transcriptome assembly --- transcriptional regulation --- ontology network --- co-expression network --- taxonomic analysis --- database contamination --- kleptoplastidy
Choose an application
Natural-based biomolecules continuously play an important role in novel drug discovery for the treatment of chronic diseases. The development of natural peptide/protein-based, toxin-based, and antibody-based drugs can significantly improve the biomedical efficiency of disease-specific therapy. The focus of this Special Issue of Biomolecules will be on the most recent advances related to novel peptides/proteins, antibodies, and toxins as forms of medicinal therapy. Recent advances in the discovery and development of these natural biomolecules for use in targeted therapy and immunotherapy against chronic diseases (e.g., cancer, diabetes, cardiovascular diseases, and rheumatoid arthritis) will be addressed. The discussion on using novel disease-specific proteins/peptides/toxins/antibodies along with currently available FDA-approved drugs as combinatorial treatments will also be encouraged in this context. Finally, an overview of some of the selected promising natural biomolecules that are potentially able to address the forthcoming challenges in this field will be included. Both research (in particular) and review articles proposing novelties or overviews, respectively, are welcome.
Humanities --- Social interaction --- DAPK1 --- SUMO --- SENP --- protein degradation --- post-translational modification --- amphibian Bowman-Birk inhibitor --- Tat peptide --- molecular cloning --- antifungal --- drug design --- protease inhibitor --- natural-based compound --- anticancer therapy --- lung cancer --- survivin --- apoptosis --- STAT3 --- colorectal cancer --- orientin --- cell cycle arrest --- Bcl-2 family proteins --- Astragalus membranaceus --- insulin --- PI3K --- AKT --- PPARγ --- PDX-1 --- Petasites japonicus --- Asteraceae --- lignan --- anti-inflammation --- NO --- PGE2 --- iNOS --- COX-2 --- molecular docking --- peptides --- kynurenines --- binding affinity --- μ-opioid receptor --- pharmacophore --- G-protein activation --- fucoidan --- PLGA --- docetaxel --- drug delivery system --- anticancer therapy/cancer treatment --- hIAPP --- amyloidogenesis --- insulin granules --- endoplasmic reticulum --- anionic lipids --- F23R variant --- β-sheet transitions --- β-cell cytotoxicity --- unfolded protein response --- pomegranate --- punicalagin --- tannins --- gingiva --- fibroblasts --- antioxidant --- wound healing --- branched-chain fatty acids --- Conidiobolus heterosporus --- peroxisome proliferator-activated receptor α --- lipid metabolism --- fatty acid oxidation --- hepatocyte --- n/a
Choose an application
Natural-based biomolecules continuously play an important role in novel drug discovery for the treatment of chronic diseases. The development of natural peptide/protein-based, toxin-based, and antibody-based drugs can significantly improve the biomedical efficiency of disease-specific therapy. The focus of this Special Issue of Biomolecules will be on the most recent advances related to novel peptides/proteins, antibodies, and toxins as forms of medicinal therapy. Recent advances in the discovery and development of these natural biomolecules for use in targeted therapy and immunotherapy against chronic diseases (e.g., cancer, diabetes, cardiovascular diseases, and rheumatoid arthritis) will be addressed. The discussion on using novel disease-specific proteins/peptides/toxins/antibodies along with currently available FDA-approved drugs as combinatorial treatments will also be encouraged in this context. Finally, an overview of some of the selected promising natural biomolecules that are potentially able to address the forthcoming challenges in this field will be included. Both research (in particular) and review articles proposing novelties or overviews, respectively, are welcome.
Humanities --- Social interaction --- DAPK1 --- SUMO --- SENP --- protein degradation --- post-translational modification --- amphibian Bowman-Birk inhibitor --- Tat peptide --- molecular cloning --- antifungal --- drug design --- protease inhibitor --- natural-based compound --- anticancer therapy --- lung cancer --- survivin --- apoptosis --- STAT3 --- colorectal cancer --- orientin --- cell cycle arrest --- Bcl-2 family proteins --- Astragalus membranaceus --- insulin --- PI3K --- AKT --- PPARγ --- PDX-1 --- Petasites japonicus --- Asteraceae --- lignan --- anti-inflammation --- NO --- PGE2 --- iNOS --- COX-2 --- molecular docking --- peptides --- kynurenines --- binding affinity --- μ-opioid receptor --- pharmacophore --- G-protein activation --- fucoidan --- PLGA --- docetaxel --- drug delivery system --- anticancer therapy/cancer treatment --- hIAPP --- amyloidogenesis --- insulin granules --- endoplasmic reticulum --- anionic lipids --- F23R variant --- β-sheet transitions --- β-cell cytotoxicity --- unfolded protein response --- pomegranate --- punicalagin --- tannins --- gingiva --- fibroblasts --- antioxidant --- wound healing --- branched-chain fatty acids --- Conidiobolus heterosporus --- peroxisome proliferator-activated receptor α --- lipid metabolism --- fatty acid oxidation --- hepatocyte --- n/a
Choose an application
This book includes a collection of eight original research articles and three reviews covering a wide range of topics in the field of kinetoplastids. In addition, readers can find a compendium of molecular biology procedures and bioinformatics tools.
Research & information: general --- Biology, life sciences --- trypanosomatids --- yeasts --- trypanosomatids genome --- cell cycle phases --- S-phase duration --- DNA replication --- replication origins --- neglected tropical diseases --- Leishmania --- Trypanosoma cruzi --- Trypanosoma brucei --- drug discovery --- in vitro models --- in vivo models --- genomics --- drug resistance --- Leishmania infantum --- proteome --- post-translational modifications (PTMs) --- proteogenomics --- mass spectrometry --- Retrotransposon Hot Spot (RHS) multigene family --- chromosome distribution --- recombination --- gene mosaic structure --- evolution --- nuclear protein --- Leishmania braziliensis --- reverse genetics --- CRISPR–Cas9 --- gene targeting --- phenotyping --- heat shock proteins --- Trypanosoma cruzi strain --- sequencing methods --- genome plasticity --- gene expression --- trans-sialidases --- mucins --- SENP --- Ulp2 --- SUMO --- CRISPR --- protease --- genome --- repeats --- 3′UTR --- multigenic family --- Leishmania donovani --- whole-genome sequencing (WGS) --- transcriptome --- artemisinin drug resistance --- Leishmania viruses --- phylogeny --- coevolution --- endosymbiont protozoan viruses --- transcriptome assembly --- transcriptional regulation --- ontology network --- co-expression network --- taxonomic analysis --- database contamination --- kleptoplastidy
Choose an application
This book includes a collection of eight original research articles and three reviews covering a wide range of topics in the field of kinetoplastids. In addition, readers can find a compendium of molecular biology procedures and bioinformatics tools.
trypanosomatids --- yeasts --- trypanosomatids genome --- cell cycle phases --- S-phase duration --- DNA replication --- replication origins --- neglected tropical diseases --- Leishmania --- Trypanosoma cruzi --- Trypanosoma brucei --- drug discovery --- in vitro models --- in vivo models --- genomics --- drug resistance --- Leishmania infantum --- proteome --- post-translational modifications (PTMs) --- proteogenomics --- mass spectrometry --- Retrotransposon Hot Spot (RHS) multigene family --- chromosome distribution --- recombination --- gene mosaic structure --- evolution --- nuclear protein --- Leishmania braziliensis --- reverse genetics --- CRISPR–Cas9 --- gene targeting --- phenotyping --- heat shock proteins --- Trypanosoma cruzi strain --- sequencing methods --- genome plasticity --- gene expression --- trans-sialidases --- mucins --- SENP --- Ulp2 --- SUMO --- CRISPR --- protease --- genome --- repeats --- 3′UTR --- multigenic family --- Leishmania donovani --- whole-genome sequencing (WGS) --- transcriptome --- artemisinin drug resistance --- Leishmania viruses --- phylogeny --- coevolution --- endosymbiont protozoan viruses --- transcriptome assembly --- transcriptional regulation --- ontology network --- co-expression network --- taxonomic analysis --- database contamination --- kleptoplastidy
Choose an application
Natural-based biomolecules continuously play an important role in novel drug discovery for the treatment of chronic diseases. The development of natural peptide/protein-based, toxin-based, and antibody-based drugs can significantly improve the biomedical efficiency of disease-specific therapy. The focus of this Special Issue of Biomolecules will be on the most recent advances related to novel peptides/proteins, antibodies, and toxins as forms of medicinal therapy. Recent advances in the discovery and development of these natural biomolecules for use in targeted therapy and immunotherapy against chronic diseases (e.g., cancer, diabetes, cardiovascular diseases, and rheumatoid arthritis) will be addressed. The discussion on using novel disease-specific proteins/peptides/toxins/antibodies along with currently available FDA-approved drugs as combinatorial treatments will also be encouraged in this context. Finally, an overview of some of the selected promising natural biomolecules that are potentially able to address the forthcoming challenges in this field will be included. Both research (in particular) and review articles proposing novelties or overviews, respectively, are welcome.
DAPK1 --- SUMO --- SENP --- protein degradation --- post-translational modification --- amphibian Bowman-Birk inhibitor --- Tat peptide --- molecular cloning --- antifungal --- drug design --- protease inhibitor --- natural-based compound --- anticancer therapy --- lung cancer --- survivin --- apoptosis --- STAT3 --- colorectal cancer --- orientin --- cell cycle arrest --- Bcl-2 family proteins --- Astragalus membranaceus --- insulin --- PI3K --- AKT --- PPARγ --- PDX-1 --- Petasites japonicus --- Asteraceae --- lignan --- anti-inflammation --- NO --- PGE2 --- iNOS --- COX-2 --- molecular docking --- peptides --- kynurenines --- binding affinity --- μ-opioid receptor --- pharmacophore --- G-protein activation --- fucoidan --- PLGA --- docetaxel --- drug delivery system --- anticancer therapy/cancer treatment --- hIAPP --- amyloidogenesis --- insulin granules --- endoplasmic reticulum --- anionic lipids --- F23R variant --- β-sheet transitions --- β-cell cytotoxicity --- unfolded protein response --- pomegranate --- punicalagin --- tannins --- gingiva --- fibroblasts --- antioxidant --- wound healing --- branched-chain fatty acids --- Conidiobolus heterosporus --- peroxisome proliferator-activated receptor α --- lipid metabolism --- fatty acid oxidation --- hepatocyte --- n/a
Listing 1 - 6 of 6 |
Sort by
|